The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic and predictive value of HER2 extracellular domain in patients with early and metastatic breast cancer treated with trastuzumab and lapatinib: Correlation with clinicopathological parameters and response.
M. Ciccarese
No relevant relationships to disclose
M. M. Galante
No relevant relationships to disclose
R. Forcignano
No relevant relationships to disclose
V. E. Chiuri
No relevant relationships to disclose
G. Cairo
No relevant relationships to disclose
G. Ronzino
No relevant relationships to disclose
G. Romano
No relevant relationships to disclose
C. Accettura
No relevant relationships to disclose
M. Giampaglia
No relevant relationships to disclose
A. Pellegrino
No relevant relationships to disclose
S. A. Leo
No relevant relationships to disclose
V. Saracino
No relevant relationships to disclose
L. Petrucelli
No relevant relationships to disclose
L. Lupo
No relevant relationships to disclose
G. Leo
No relevant relationships to disclose
M. PisanĂ²
No relevant relationships to disclose
V. Lorusso
No relevant relationships to disclose